ARCHIVES

In Appropriations Hearings, Groups Seek NCI Bypass Budget, Differ On CDC Funding.

This article is from The Cancer Letter archive.

Vol. 26 No. 14 | April 7, 2000

Download PDF Visit The Full Archive

Related Articles

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

Senate Confirms FDA Commissioner Von Eschenbach.

December 8, 2006

New NCAB Weak In Grant Reviews, Confused By Issues

December 10, 1982

Cancer Letter Founder Receives ACCC Award, Stresses Importance Of Bypass Budget

March 20, 1992

NCI T Phase Out Support Of VA Lung Group, But Will Continue Funding VASAG

November 3, 1978

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

November 3, 1995